A Move On Bridging Trials, An Indemnity Suggestion Could Help Covid-19 Vaccine Plan. Here's How
3 years, 6 months ago

A Move On Bridging Trials, An Indemnity Suggestion Could Help Covid-19 Vaccine Plan. Here's How

News 18  

One key step by India’s drug regulator and a hint by government officials could pave the way for faster arrival of foreign Covid-19 vaccines, including those by Pfizer and Moderna, to the country that aims to inoculate all its citizens by December-end. First, the Drug Controller General of India has said post-approval bridging trials and the mandatory testing of every batch of foreign vaccines may not be necessary if the “vaccine batch/lot” has been “certified and released” by authorities in the country of origin. The move to do away with bridging trials — and the indemnity move, as suggested by the sources — could expedite the arrival of the widely used jabs by Pfizer and Moderna, bolster India’s ambitious inoculation programme and augment overall supply of vaccines, as the country strives to control a brutal second wave of Covid-19 infections and prepare for a possible third wave. Pfizer’s Covid-19 vaccine may be available in India by July, the Centre has hinted, before the suggestion on indemnity grabbed headlines.

India Johnson Pfizer Indemnity Moderna Vaccines Bridging Trials  heres  india  report  suggestion  sources  vaccine  moderna  vaccines  johnson  plan  bridging  help  pfizer  indemnity  trials  covid19

History of this topic

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 1 month ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 6 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

Centre no longer to procure Covid vaccines for states
1 year, 8 months ago

Centre no longer to procure Covid vaccines for states

Deccan Chronicle  

HYDERABAD: The Centre will no longer follow its practice of procuring Covid-19 vaccines for the states, health minister T. Harish Rao said on Friday, following a decision taken at a meeting on Covid-19 preparedness headed by Union health minister Dr Mansaukh Mandaviya. Harish Rao, in a press note, said the Union minister had advised state governments to procure vaccines from …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 9 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 9 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 11 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it
1 year, 11 months ago

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it

News 18  

Pfizer CEO Albert Bourla being quizzed at Davos by journalists about the company’s Covid-19 vaccine has triggered the BJP to take on top Congress and AAP leaders for earlier pushing for the Pfizer shot to be brought to India. But facts show that not only was the vaccine offered by Pfizer and Moderna exorbitantly priced at over $20 for each …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
1 year, 11 months ago

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above according to reports will be available at ₹800+ GST+ hospital charges according to sources. The country’s first intranasal covid vaccine will be rolled out in the fourth week of January as a booster dose for those …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

A PLI-type scheme for 'atmanirbhar' vaccine industry
2 years ago

A PLI-type scheme for 'atmanirbhar' vaccine industry

Live Mint  

The government will likely unveil a ₹2,500 crore financial assistance programme to boost domestic production of vaccine raw materials to enhance self-reliance amid a resurgence of covid cases worldwide, two officials familiar with the development said. Cement investors see Q3 with mixed feelings While India is a global leader in vaccine production, it imports key raw materials needed for manufacturing. …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha
2 years ago

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha

News 18  

There has been no wastage of COVID-19 vaccines in the government buffer stock due to expiry, Union minister Bharati Pravin Pawar informed Lok Sabha on Friday. The central government closely monitors COVID-19 vaccine stocks in states and Union territories so as to ensure their optimal utilisation and minimal wastage, Pawar said in written reply to a question. To ensure utilisation …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 3 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

Monkeypox vaccines: India puts emergency buying on hold for now - here’s why
2 years, 3 months ago

Monkeypox vaccines: India puts emergency buying on hold for now - here’s why

Live Mint  

According to those with knowledge of the situation, India has chosen to delay purchasing the monkeypox vaccine on an emergency basis for the time being because the number of cases reported across the nation has not increased. Serum Institute of India, one of the first organisations to express interest in bringing the monkeypox vaccine into India, put its proposal on …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

Tackling the new variants
2 years, 4 months ago

Tackling the new variants

Hindustan Times  

The first redesigned coronavirus vaccine was approved for use this week when authorities in the United Kingdom cleared a Moderna dose that the company adapted to create immunity against the Omicron variant. The vaccine is a 50-50 formulation of Moderna’s 2020 product, designed on the Sars-CoV-2 variant that first spread around the world, and of a new dose developed using …

Why India’s 75-Day Free Booster Drive is a Smart Move and How Can it be Made Smarter
2 years, 5 months ago

Why India’s 75-Day Free Booster Drive is a Smart Move and How Can it be Made Smarter

News 18  

To facilitate and enhance the ongoing mass vaccination campaign for Covid-19, the government has made booster doses free for citizens above 18 years of age for 75 days, starting July 15. Record-Breaking Numbers The first day of the 75-day campaign saw 13.2 lakh doses of the booster shot being administered to 18-60-year-olds, a 16-fold jump over the pace thus far. …

Free Covid booster doses will create healthier country: PM Modi
2 years, 5 months ago

Free Covid booster doses will create healthier country: PM Modi

India Today  

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free precautionary doses of Covid-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country. As part of 'Azadi Ka Amrit Mahotsav' celebrations, free precautionary doses of Covid-19 vaccines will be administered to all citizens above the age of 18 at …

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine
2 years, 5 months ago

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine

India Today  

The Centre has invested in developing a strain specific vaccine that would help in countering the changing nature of coronavirus. An official who facilitated developing this ecosystem for second generation vaccines told India Today that research and development work is underway to develop strain-specific vaccines in India. A bivalent vaccine will target the specific spike mutations seen in the Omicron …

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence
2 years, 6 months ago

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence

News 18  

With the UK-India week on the cusp, it becomes pertinent to discuss how the United Kingdom and India have weathered rough storms during the pandemic years to come out closer than ever. It is this three-way partnership that has now been at the helm of having already delivered over 2 billion affordable, effective vaccines which have now been administered to …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora
2 years, 6 months ago

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora

News 18  

Not so long back, a reputed international media-house had predicted gloomily that it could take over a decade for India to vaccinate its 1.4 billion population against Covid-19. The resounding success of this drive, which has been a proactive, pre-emptive, and graded response in the management of Covid-19 has been a myth-breaker on several fronts in the public health space …

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing
2 years, 7 months ago

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing

The Hindu  

Hailing India for ramping up its COVID-19 vaccine manufacturing at the right time and for ensuring supplies to the rest of the world, leaders at the World Economic Forum on Monday said everyone else needs to follow the Indian model to ensure vaccine equity and wider inoculation. Bucher said India has been a good example and the same needs to …

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs
2 years, 7 months ago

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs

The Hindu  

As India nears the 200-crore COVID-19 vaccination mark, Serum Institute of India’s Covishield accounts for 80 per cent of the jabs, while Bharat Biotech’s Covaxin accounts for 16.75 per cent jabs. As of date, India has granted emergency usage authorisation to nine COVID-19 vaccine candidates in total – Covishield, Covaxin, Covovax, Corbevax, Zydus Cadila’s ZyCoV-D, Moderna’s Spikevax, Sputnik-V, Sputnik Light, …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

Firstpost  

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that “Made in India” COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. “The …

Too little, too late: The Hindu Editorial on COVID-19 vaccines and patent rights
2 years, 9 months ago

Too little, too late: The Hindu Editorial on COVID-19 vaccines and patent rights

The Hindu  

In 2020, a key question that the pandemic posed was whether nations would act in solidarity and prioritise equity for the larger good over narrow self-interest. It was amid this turmoil that India and South Africa had proposed at the WTO that all patent rights for COVID-19 vaccines, drugs and diagnostics be temporarily suspended to ensure smooth manufacture and distribution. …

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms
2 years, 9 months ago

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms

News 18  

Speaking of vaccine development, never before has India incubated companies by engaging in proactive risk financing on a scale as enormous as this. NEGVAC’s vaccination strategy was based on two components: the information coming in simultaneously from the manufacturers that vaccine availability would be limited in the first six months due to restrictions in their capacities. At the same time, …

Patent rights on COVID-19 vaccines may be waived for five years
2 years, 9 months ago

Patent rights on COVID-19 vaccines may be waived for five years

The Hindu  

Intellectual property rights held by international pharmaceutical companies on COVID-19 vaccines may be relaxed for up to five years, according to a proposal by the European Union in the backdrop of a festering two-year-old dispute at the World Trade Organisation involving India, U.S., South Africa and the EU. This reprieve will, however, not apply to COVID-19 drugs and diagnostic devices, …

Being ready: The Hindu Editorial on vaccination and India’s third COVID-19 wave
2 years, 9 months ago

Being ready: The Hindu Editorial on vaccination and India’s third COVID-19 wave

The Hindu  

The COVID-19 pandemic is on a discernible wane. Balram Bhargava, Director-General, ICMR, said at a press conference this week that 92% of those who died of COVID-19 since January this year were unvaccinated, and underlined that vaccines and the wide vaccination coverage had played an important role in protecting hundreds of lives. The initial scepticism regarding the vaccines not having …

Covid-19 | India Likely To Supply Covovax, Corbevax Vaccines To Quad Partners: Report
2 years, 10 months ago

Covid-19 | India Likely To Supply Covovax, Corbevax Vaccines To Quad Partners: Report

ABP News  

New Delhi: India on Friday conveyed to the Quad partners that New Delhi is open to supplying Covid-19 vaccines, including Covovax and Corbevax, manufactured in the country under the vaccine partnership. “As pandemic continues to impact us, we have undertaken collective efforts to address global health security, Quad vaccine initiative and our collective vaccine delivery. Australian Foreign Minister Marise Payne …

India’s first mRNA COVID-19 vaccine likely to be rolled out by April
2 years, 10 months ago

India’s first mRNA COVID-19 vaccine likely to be rolled out by April

The Hindu  

Data from human trials of India’s first homegrown mRNA COVID-19 vaccine are likely to be presented to authorities for evaluation by the end of the month, and company officials are aiming to roll out the product before April, two senior scientists connected to the Department of Biotechnology told The Hindu. The mRNA vaccine being developed by Pune-based Gennova Biopharmaceuticals is …

How conditional market authorisation to Covishield and Covaxin will change India’s COVID-19 vaccine drive
2 years, 10 months ago

How conditional market authorisation to Covishield and Covaxin will change India’s COVID-19 vaccine drive

Firstpost  

Highly-placed sources have said that the conditional market authorisation will now allow the two vaccines to be made available at private hospitals and clinics at pre-decided costs India’s COVID-19 vaccination drive is about to witness a change after the drug regulator on Thursday granted a conditional market authorisation for Covishield and Covaxin, the two coronavirus vaccines widely used in the …

‘Omicron a Self-Inflicted Wound’: Patent-Free Corbevax Can Help End Covid Pandemic, Believe Its Makers
2 years, 11 months ago

‘Omicron a Self-Inflicted Wound’: Patent-Free Corbevax Can Help End Covid Pandemic, Believe Its Makers

News 18  

“When your house is on fire, you call the fire department not lawyers,” that’s how American scientist Prof. Peter Hotez explained the importance of patent waiver for Covid-19 vaccines. Professor Hotez in an exclusive interview to CNN News-18 said he along with Dr Maria Elena Bottazzi developed Corbevax and kept patents off the table to “help lower- and middle-income countries …

India Starts Administering Precautionary Covid Vaccine Shot From Today - All You Need To Know
2 years, 11 months ago

India Starts Administering Precautionary Covid Vaccine Shot From Today - All You Need To Know

ABP News  

Amid the surge in Covid-19 cases in the country, the importance of taking a precautionary vaccine shot has become imminent. The government has a plan to roll out the booster dose or the precautionary vaccine shot from today, i.e. There is no requirement for new registration for the beneficiaries of precautionary Covid-19 vaccine dose, said the Ministry of Health and …

COVID-19 'precautionary' vaccine: Appointments for third dose to open today; check details here
2 years, 11 months ago

COVID-19 'precautionary' vaccine: Appointments for third dose to open today; check details here

Firstpost  

The Centre has already notified the states and Union territories that for each recipient, the third dose would be the same shot that was used for the first two doses Appointments for the ‘precautionary dose’ of the COVID-19 vaccine in India will begin today, 8 January, according to the announcement made by the central government. The three priority groups of …

India achieves 150-crore COVID-19 vaccination milestone
2 years, 11 months ago

India achieves 150-crore COVID-19 vaccination milestone

Op India  

COVID-19 vaccination drive in India has reached a new milestone on 7th January 2022. Bharat Biotech’s Covaxin and Serum Institute’s Covishield were the vaccines adopted by India to roll on and carry out this vaccination drive. One billion within ten months On 21st October 2021, India’s COVID-19 vaccination coverage crossed an important milestone of the 100 crore mark. From opposition …

2022, Here We Go Again; the Games India Plays With COVID-19 Vaccines
2 years, 11 months ago

2022, Here We Go Again; the Games India Plays With COVID-19 Vaccines

The Quint  

Another traffic jam, no food or water in the car and the FM radio station is playing power ballads, all the liquid that we have imbibed is not helping, but we are even now, only honking away again. Why do we not have data about the efficacy of our vaccines against the Delta variant, let alone Omicron? Why have we …

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines
2 years, 11 months ago

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines

The Hindu  

Heralding a new frontier in India’s vaccination programme, the apex drug regulator has approved two more vaccines under emergency use authorisation, and an antiviral drug. Despite three vaccines being available, India has overwhelmingly been reliant on Covishield and that is a matter of concern as a new chapter in the vaccination programme unfolds. The new directives say that “precaution doses”, …

Discover Related